Systemic lupus erythematosus (SLE)—chronic autoimmune disease affecting millions worldwide—now tied to Epstein-Barr virus (EBV), present in >95% adults. New study reveals mechanism resolving decades-old scientific mystery.​

Lupus and Its Clinical Impacts

Lupus attacks body’s own tissues: rashes, persistent fatigue, severe organ damage (lungs/kidneys).

Selena Gomez diagnosed age 20; 2017 kidney transplant from complications. Highlights scope: >5 million affected globally.​

Causes unclear—genetics factor, but EBV (infectious mononucleosis cause) long suspected trigger.

Key challenge: how ubiquitous virus sparks devastating autoimmunity?

B Lymphocytes’ Role in Disease

Stanford Medicine-led study used innovative tech to ID EBV-infected B cells, analyze activated genes.

B lymphocytes produce antibodies, present antigens alerting immunity. Normally ~20% autoreactive but inactive.

Healthy: <1/10,000 B cells EBV-infected. Lupus patients: 1/400—25x higher.​

EBV activates molecular switch gene, sparking inflammatory cascade. Transforms B cells into antigen-presenting cells activating dormant autoreactive immunity—self-tissue attack.

Explains virus as lupus trigger, potentially other autoimmunities.

Lupus Research Implications/Future

Stanford Medicine-led study used innovative tech to ID EBV-infected B cells, analyze activated genes.

B lymphocytes produce antibodies, present antigens alerting immunity. Normally ~20% autoreactive but inactive.

Healthy: <1/10,000 B cells EBV-infected. Lupus patients: 1/400—25x higher.​

EBV activates molecular switch gene, sparking inflammatory cascade. Transforms B cells into antigen-presenting cells activating dormant autoreactive immunity—self-tissue attack.

Explains virus as lupus trigger, potentially other autoimmunities.

Lupus Research Implications/Future

Referencia: 

• Science Translational Medicine/Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus. Link

Esta entrada también está disponible en: Español